Monday, September 15, 2025
HomeIndustriesHealthcare

Healthcare

PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company

PolarityTE, Inc., a biotechnology company developing regenerative tissue products and biomaterials announced that it signed a non-binding letter of intent (the "LOI") with Michael...

ZielBio Receives Orphan Drug Designation for ZB131 for the Treatment of Pancreatic Cancer

ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer and other serious diseases through its innovative drug discovery platform, announced that the...

Miravo Healthcare Enters into Definitive Agreement to be Acquired by Searchlight Pharma

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare and Searchlight Pharma Inc., a private Canadian-based specialty healthcare company, are pleased to announce that they have entered...

State of Arizona Support for CND Life Sciences to Launch Groundbreaking Digital Biosignatures Lab

CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, has been awarded...

Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22

Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced that for the first time, a...
0FansLike
0FollowersFollow
spot_img

Hot Topics